inDNA Life Sciences Pvt Ltd

There has been a giant leap from blood based Diagnostics to DNA based diagnostics and the promise of text book molecular life sciences has become a clinical and diagnostic reality today. We are in the inflection point of integrating the ever changing paradigm of Molecular Life sciences, cutting edge soft biology, deep learning tools and the exciting power of a possibility of knowing the disease in advance. The diagnostic industry has undergone a sea change and Molecular Dx is a billion dollar industry today. The current estimate of Indian DNA based Diagnostics Industry in itself is 6 billion dollar and growing at a rapid CAGR of over 15%. The rapid growth process was initiated in the last decade, from 2010 onwards and is just gathering steam to acquire a huge accelerating pace and is poised to touch astronomical heights by 2025. In this era of molecular diagnostics, the market is also witnessing a rapid growth of preventive or wellness industry of predictive medicine. inDNA Life Sciences Pvt Ltd is India’s first indigenous DNA based diagnostics platform which is aiming to offer the DNA based Diagnostics solutions in the areas of Clinical Oncology, Preventive Oncology, Molecular infertility, Prenatal Screening, New Born Screening, Life Style Disorder and Wellness. inDNA Life Sciences has taken the first steps to personalize disease management by offering a range of DNA based solutions, to a range of clinical problems, in the fields of Cytogenetics, Cancer, Genetic Disorders, and Mendelian defects. Although the Company was formally founded and legalized in the month of May 2012, but a lot of research and validation has gone in since last decade by the founder Dr. Birendranath Banerjee and his team. In the year 2018-19 genomics is in the same nascent stage as the software industry was in the late eighties and nineties. inDNA believes that they will be able to make genomics and molecular medicine training accessible globally.